|
Market Cap (18-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 18 November 2021, 9:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 261.46kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.011% short sold according to ASIC data. It was ranked the 603rd most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Site Initiation Visit Completed for CYP DFU Clinical Trial | 18 November 2021, 9:20 |
| Results of Annual General Meeting | 16 November 2021, 13:55 |
| AGM Presentations | 16 November 2021, 9:48 |
| Quarterly Activity Report & Appendix 4C | 28 October 2021, 12:42 |
You must be logged in to post a reply.
Cynata Therapeutics 